Lukas M. Orre

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance.

Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance.

Journal: NPJ precision oncology
Published: March 26, 2026

Integrated prediction of lung cancer histology and molecular profiles from small bronchoscopic tumor specimens.

Integrated prediction of lung cancer histology and molecular profiles from small bronchoscopic tumor specimens.

Journal: NPJ precision oncology
Published: February 13, 2026

Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides.

Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides.

Journal: NPJ precision oncology
Published: January 20, 2026

Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics.

Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics.

Journal: NPJ precision oncology
Published: September 08, 2025

Landscape of circular RNAs in acute myeloid leukemia and their clinical significance.

Landscape of circular RNAs in acute myeloid leukemia and their clinical significance.

Journal: NPJ precision oncology
Published: August 23, 2025

Pathway activation model for personalized prediction of drug synergy.

Pathway activation model for personalized prediction of drug synergy.

Journal: eLife
Published: June 03, 2025

Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer.

Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer.

Journal: iScience
Published: May 08, 2024

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Journal: Leukemia
Published: March 28, 2024

Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma.

Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma.

Journal: Cell reports. Medicine
Published: February 26, 2024

Delineating functional and molecular impact of ex vivo sample handling in precision medicine.

Delineating functional and molecular impact of ex vivo sample handling in precision medicine.

Journal: NPJ precision oncology
Published: June 16, 2023

Prediction model for drug response of acute myeloid leukemia patients.

Prediction model for drug response of acute myeloid leukemia patients.

Journal: NPJ precision oncology
Published: October 06, 2022

FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.

FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress.

Journal: Molecular cell
Published: June 16, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026